Atossa Therapeutics (ATOS) Other Accumulated Expenses (2012 - 2026)
Atossa Therapeutics (ATOS) posted Other Accumulated Expenses of $1.12 million for Q2 2026, down 27.8% from $1.56 million a year earlier and down 1.3% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
At the end of FY2025, Atossa Therapeutics' Other Accumulated Expenses came in at $1.1 million, down 27.0% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 207.5% (FY2020 to FY2025).
- In prior years, Atossa Therapeutics' Other Accumulated Expenses was $1.51 million in FY2024 (-16.4%), $1.8 million in FY2023, $19,000 in FY2022 (-9.5%) and $21,000 in FY2021 (+425.0%).
- Quarterly Other Accumulated Expenses has run from a low of $13,000 in Q1 2022 to a high of $1.83 million in Q1 2024 over five years.
- On a year-over-year basis, Other Accumulated Expenses has declined in each of the last three quarters, with an average decline of 17.4% over the last seven quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2021, with growth of 425.0%; the weakest was Q2 2026, with a decline of 27.8%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $1.14 million (Q1 2026), $1.1 million (Q4 2025) and $1.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Atossa Therapeutics | 23.35 Mn | 23.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 1.80 Mn |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 46,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 18,251.00 |
API Access
Atossa Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();